Uniphar (UPR) Competitors

Spire Healthcare Group presently has a consensus price target of GBX 247.50, suggesting a potential upside of 0.61%. Given Spire Healthcare Group's stronger consensus rating and higher possible upside, analysts plainly believe Spire Healthcare Group is more favorable than Uniphar.

Uniphar has higher revenue and earnings than Spire Healthcare Group. Uniphar is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

21.8% of Spire Healthcare Group shares are held by institutional investors. Comparatively, 38.9% of Uniphar shares are held by institutional investors. 39.3% of Spire Healthcare Group shares are held by company insiders. Comparatively, 7.9% of Uniphar shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Spire Healthcare Group pays an annual dividend of GBX 2.30 per share and has a dividend yield of 0.9%. Uniphar pays an annual dividend of GBX 1.96 per share and has a dividend yield of 0.6%. Spire Healthcare Group pays out 57.5% of its earnings in the form of a dividend. Uniphar pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Uniphar has a net margin of 1.69% compared to Spire Healthcare Group's net margin of 1.04%. Uniphar's return on equity of 12.80% beat Spire Healthcare Group's return on equity.

Spire Healthcare Group has a beta of 0.932, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Uniphar has a beta of 1.102, indicating that its stock price is 10% more volatile than the broader market.

In the previous week, Spire Healthcare Group had 5 more articles in the media than Uniphar. MarketBeat recorded 5 mentions for Spire Healthcare Group and 0 mentions for Uniphar. Spire Healthcare Group's average media sentiment score of 0.50 beat Uniphar's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the media.

Medica Group has a net margin of 9.35% compared to Uniphar's net margin of 1.69%. Uniphar's return on equity of 12.80% beat Medica Group's return on equity.

In the previous week, Uniphar's average media sentiment score of 0.00 equaled Medica Group'saverage media sentiment score.

Uniphar has higher revenue and earnings than Medica Group. Medica Group is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

Uniphar has a beta of 1.102, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Medica Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

38.9% of Uniphar shares are held by institutional investors. Comparatively, 88.4% of Medica Group shares are held by institutional investors. 7.9% of Uniphar shares are held by company insiders. Comparatively, 2.9% of Medica Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Uniphar pays an annual dividend of GBX 1.96 per share and has a dividend yield of 0.6%. Medica Group pays an annual dividend of GBX 3 per share. Uniphar pays out 10.1% of its earnings in the form of a dividend. Medica Group pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Uniphar is clearly the better dividend stock, given its higher yield and lower payout ratio.

38.9% of Uniphar shares are owned by institutional investors. 7.9% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Uniphar has a net margin of 1.69% compared to Sourcebio International's net margin of 0.00%. Uniphar's return on equity of 12.80% beat Sourcebio International's return on equity.

In the previous week, Sourcebio International's average media sentiment score of 0.00 equaled Uniphar'saverage media sentiment score.

Uniphar has higher revenue and earnings than Sourcebio International. Sourcebio International is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

In the previous week, Uniphar's average media sentiment score of 0.00 equaled One Health Group'saverage media sentiment score.

Uniphar has a net margin of 1.69% compared to One Health Group's net margin of 0.00%. Uniphar's return on equity of 12.80% beat One Health Group's return on equity.

Uniphar pays an annual dividend of GBX 1.96 per share and has a dividend yield of 0.6%. One Health Group pays an annual dividend of GBX 6.23 per share and has a dividend yield of 2.1%. Uniphar pays out 10.1% of its earnings in the form of a dividend. One Health Group pays out 41.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

38.9% of Uniphar shares are owned by institutional investors. Comparatively, 12.5% of One Health Group shares are owned by institutional investors. 7.9% of Uniphar shares are owned by insiders. Comparatively, 46.1% of One Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Uniphar has higher revenue and earnings than One Health Group. Uniphar is trading at a lower price-to-earnings ratio than One Health Group, indicating that it is currently the more affordable of the two stocks.